US Stock MarketDetailed Quotes

HEPA Hepion Pharmaceuticals

Watchlist
  • 0.6345
  • -0.0156-2.39%
Close Nov 4 16:00 ET
  • 0.6345
  • 0.00000.00%
Post 20:01 ET
3.68MMarket Cap-98P/E (TTM)

Hepion Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
12.12%-10.93M
55.97%-3.62M
-16.96%-40.89M
-87.63%-9M
10.36%-11.24M
-65.82%-12.44M
18.90%-8.21M
-11.97%-34.96M
35.01%-4.8M
-10.70%-12.53M
Net income from continuing operations
72.12%-3.93M
78.48%-2.85M
-15.94%-48.93M
-62.37%-11.06M
-23.16%-10.53M
29.29%-14.08M
-91.35%-13.26M
-28.96%-42.2M
29.94%-6.81M
7.79%-8.55M
Operating gains losses
---3.28M
---1.16M
--1.32M
----
----
----
----
----
----
----
Depreciation and amortization
--0
70.53%30.76K
-13.34%67.13K
-33.62%12.27K
4.35%18.5K
-1.07%18.33K
-20.65%18.04K
-10.01%77.46K
-21.09%18.48K
-23.28%17.73K
Deferred tax
----
----
---409.02K
----
----
----
----
--0
----
----
Other non cash items
-1,313.48%-1.25M
3,610.29%1.8M
-6.03%-440K
-225.00%-260K
-275.00%-140K
1.74%-88.43K
114.90%48.43K
-117.97%-414.99K
-111.11%-80K
-89.33%80K
Change In working capital
-190.26%-2.5M
-170.07%-2.14M
-5.76%2.97M
-205.41%-1.94M
80.71%-906.71K
-73.46%2.77M
168.67%3.05M
156.63%3.15M
146.18%1.84M
-9.45%-4.7M
-Change in prepaid assets
-298.98%-1.04M
-85.34%364.26K
191.62%2.68M
-156.03%-812.39K
-59.68%478.94K
-81.24%523.93K
155.06%2.48M
120.41%917.31K
150.81%1.45M
136.41%1.19M
-Change in payables and accrued expense
-165.39%-1.47M
-540.73%-2.5M
-86.51%302.92K
-384.90%-1.13M
76.48%-1.38M
-70.64%2.25M
642.59%566.62K
310.30%2.25M
129.25%395.96K
-470.31%-5.89M
-Change in other current assets
--31.29K
-39.00%30.86K
-64.51%89.83K
-20.98%39.24K
--0
--0
-24.69%50.59K
0.12%253.1K
-24.16%49.66K
--68.54K
-Change in other current liabilities
---21.18K
37.05%-33.75K
63.28%-96.71K
18.92%-42.13K
98.65%-964
--0
23.03%-53.61K
-1.85%-263.38K
22.93%-51.96K
-4.12%-71.28K
Cash from discontinued investing activities
Operating cash flow
12.12%-10.93M
55.97%-3.62M
-16.96%-40.89M
-87.63%-9M
10.36%-11.24M
-65.82%-12.44M
18.90%-8.21M
-11.97%-34.96M
35.01%-4.8M
-10.70%-12.53M
Investing cash flow
Cash flow from continuing investing activities
-1.66%-14.3K
97.87%-348
2.58K
89.21%-14.07K
-1,633,700.00%-16.34K
0
Net PPE purchase and sale
----
----
-1.66%-14.3K
97.87%-348
--2.58K
----
----
89.21%-14.07K
-1,633,700.00%-16.34K
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
-1.66%-14.3K
97.87%-348
--2.58K
-829.83%-16.54K
--0
89.21%-14.07K
-1,633,700.00%-16.34K
--0
Financing cash flow
Cash flow from continuing financing activities
0
1.85M
187.49%4.49M
243.27%4.49M
0
0
0
-106.27%-5.14M
-3.14M
0
Net preferred stock issuance
----
----
--0
----
----
----
----
---3.14M
----
----
Proceeds from stock option exercised by employees
--0
--1.85M
--4.49M
----
----
--0
--0
--0
----
----
Net other financing activities
----
----
----
----
----
----
----
---2M
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
--1.85M
187.49%4.49M
243.27%4.49M
--0
--0
--0
-106.27%-5.14M
---3.14M
--0
Net cash flow
Beginning cash position
-69.52%13.11M
-71.12%14.79M
-43.96%51.19M
-67.40%19.28M
-57.44%30.52M
-45.73%42.99M
-43.96%51.19M
124.30%91.35M
-40.09%59.15M
-34.87%71.71M
Current changes in cash
12.24%-10.93M
78.49%-1.77M
9.24%-36.41M
43.32%-4.51M
10.38%-11.23M
-66.09%-12.45M
32.28%-8.21M
-179.24%-40.11M
-7.71%-7.95M
-10.34%-12.53M
Effect of exchange rate changes
-229.53%-61.75K
361.61%86.71K
110.66%5.02K
288.17%8.97K
85.72%-3.99K
-6.57%-18.74K
492.74%18.78K
---47.14K
---4.77K
---27.96K
End cash Position
-93.07%2.12M
-69.52%13.11M
-71.12%14.79M
-71.12%14.79M
-67.40%19.28M
-57.44%30.52M
-45.73%42.99M
-43.96%51.19M
-43.96%51.19M
-40.09%59.15M
Free cash flow
12.24%-10.93M
55.97%-3.62M
-16.94%-40.9M
-87.01%-9M
10.38%-11.23M
-66.04%-12.45M
18.90%-8.21M
-11.55%-34.98M
34.79%-4.81M
-10.34%-12.53M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 12.12%-10.93M55.97%-3.62M-16.96%-40.89M-87.63%-9M10.36%-11.24M-65.82%-12.44M18.90%-8.21M-11.97%-34.96M35.01%-4.8M-10.70%-12.53M
Net income from continuing operations 72.12%-3.93M78.48%-2.85M-15.94%-48.93M-62.37%-11.06M-23.16%-10.53M29.29%-14.08M-91.35%-13.26M-28.96%-42.2M29.94%-6.81M7.79%-8.55M
Operating gains losses ---3.28M---1.16M--1.32M----------------------------
Depreciation and amortization --070.53%30.76K-13.34%67.13K-33.62%12.27K4.35%18.5K-1.07%18.33K-20.65%18.04K-10.01%77.46K-21.09%18.48K-23.28%17.73K
Deferred tax -----------409.02K------------------0--------
Other non cash items -1,313.48%-1.25M3,610.29%1.8M-6.03%-440K-225.00%-260K-275.00%-140K1.74%-88.43K114.90%48.43K-117.97%-414.99K-111.11%-80K-89.33%80K
Change In working capital -190.26%-2.5M-170.07%-2.14M-5.76%2.97M-205.41%-1.94M80.71%-906.71K-73.46%2.77M168.67%3.05M156.63%3.15M146.18%1.84M-9.45%-4.7M
-Change in prepaid assets -298.98%-1.04M-85.34%364.26K191.62%2.68M-156.03%-812.39K-59.68%478.94K-81.24%523.93K155.06%2.48M120.41%917.31K150.81%1.45M136.41%1.19M
-Change in payables and accrued expense -165.39%-1.47M-540.73%-2.5M-86.51%302.92K-384.90%-1.13M76.48%-1.38M-70.64%2.25M642.59%566.62K310.30%2.25M129.25%395.96K-470.31%-5.89M
-Change in other current assets --31.29K-39.00%30.86K-64.51%89.83K-20.98%39.24K--0--0-24.69%50.59K0.12%253.1K-24.16%49.66K--68.54K
-Change in other current liabilities ---21.18K37.05%-33.75K63.28%-96.71K18.92%-42.13K98.65%-964--023.03%-53.61K-1.85%-263.38K22.93%-51.96K-4.12%-71.28K
Cash from discontinued investing activities
Operating cash flow 12.12%-10.93M55.97%-3.62M-16.96%-40.89M-87.63%-9M10.36%-11.24M-65.82%-12.44M18.90%-8.21M-11.97%-34.96M35.01%-4.8M-10.70%-12.53M
Investing cash flow
Cash flow from continuing investing activities -1.66%-14.3K97.87%-3482.58K89.21%-14.07K-1,633,700.00%-16.34K0
Net PPE purchase and sale ---------1.66%-14.3K97.87%-348--2.58K--------89.21%-14.07K-1,633,700.00%-16.34K--0
Cash from discontinued investing activities
Investing cash flow --0--0-1.66%-14.3K97.87%-348--2.58K-829.83%-16.54K--089.21%-14.07K-1,633,700.00%-16.34K--0
Financing cash flow
Cash flow from continuing financing activities 01.85M187.49%4.49M243.27%4.49M000-106.27%-5.14M-3.14M0
Net preferred stock issuance ----------0-------------------3.14M--------
Proceeds from stock option exercised by employees --0--1.85M--4.49M----------0--0--0--------
Net other financing activities -------------------------------2M--0--0
Cash from discontinued financing activities
Financing cash flow --0--1.85M187.49%4.49M243.27%4.49M--0--0--0-106.27%-5.14M---3.14M--0
Net cash flow
Beginning cash position -69.52%13.11M-71.12%14.79M-43.96%51.19M-67.40%19.28M-57.44%30.52M-45.73%42.99M-43.96%51.19M124.30%91.35M-40.09%59.15M-34.87%71.71M
Current changes in cash 12.24%-10.93M78.49%-1.77M9.24%-36.41M43.32%-4.51M10.38%-11.23M-66.09%-12.45M32.28%-8.21M-179.24%-40.11M-7.71%-7.95M-10.34%-12.53M
Effect of exchange rate changes -229.53%-61.75K361.61%86.71K110.66%5.02K288.17%8.97K85.72%-3.99K-6.57%-18.74K492.74%18.78K---47.14K---4.77K---27.96K
End cash Position -93.07%2.12M-69.52%13.11M-71.12%14.79M-71.12%14.79M-67.40%19.28M-57.44%30.52M-45.73%42.99M-43.96%51.19M-43.96%51.19M-40.09%59.15M
Free cash flow 12.24%-10.93M55.97%-3.62M-16.94%-40.9M-87.01%-9M10.38%-11.23M-66.04%-12.45M18.90%-8.21M-11.55%-34.98M34.79%-4.81M-10.34%-12.53M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --------------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data